Back
44
50
Day Range
$1.66
$2.24
52-Week Range
$1.64
$2.85
Volume
400
50D / 200D Avg
$2.24
/
$2.34
Prev Close
$2.24
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (327 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 8.7 | 13.0 |
| P/B | 1.5 | 1.4 |
| ROE % | 18.0 | 12.6 |
| Net Margin % | 1.6 | 6.4 |
| Rev Growth 5Y % | 4.9 | 4.9 |
| D/E | 1.2 | 0.6 |
Key Takeaways
Revenue grew 4.88% annually over 5 years — modest growth
ROE of 18.03% — decent returns on equity
Generating 390.50M in free cash flow
P/E of 8.68 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.98%
Cash machine — converts 137.84% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.88%
Revenue (1Y)8.86%
Earnings (1Y)10.15%
FCF Growth (3Y)33.05%
Quality
Return on Equity
18.03%
ROIC10.61%
Net Margin1.64%
Op. Margin2.87%
Safety
Debt / Equity
1.16
Current Ratio1.04
Interest Coverage6.58
Valuation
P/E Ratio
8.68
P/B Ratio1.51
EV/EBITDA8.57
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.86% | Revenue Growth (3Y) | 4.70% |
| Earnings Growth (1Y) | 10.15% | Earnings Growth (3Y) | 4.59% |
| Revenue Growth (5Y) | 4.88% | Earnings Growth (5Y) | 4.34% |
| Profitability | |||
| Revenue (TTM) | 17.32B | Net Income (TTM) | 283.30M |
| ROE | 18.03% | ROA | 4.11% |
| Gross Margin | 12.95% | Operating Margin | 2.87% |
| Net Margin | 1.64% | Free Cash Flow (TTM) | 390.50M |
| ROIC | 10.61% | FCF Growth (3Y) | 33.05% |
| Safety | |||
| Debt / Equity | 1.16 | Current Ratio | 1.04 |
| Interest Coverage | 6.58 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 8.68 | P/B Ratio | 1.51 |
| P/S Ratio | 0.14 | PEG Ratio | 0.00 |
| EV/EBITDA | 8.57 | Dividend Yield | 0.05% |
| Market Cap | 2.46B | Enterprise Value | 4.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.32B | 15.91B | 15.80B | 15.16B | 14.32B |
| Net Income | 283.30M | 257.20M | 259.00M | 245.40M | 239.00M |
| EPS (Diluted) | 0.26 | 0.26 | 0.27 | 0.25 | 0.23 |
| Gross Profit | 2.24B | 1.94B | 1.84B | 1.68B | 1.48B |
| Operating Income | 497.30M | 480.40M | 438.60M | 409.60M | 385.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.89B | 5.80B | 5.38B | 5.20B | 4.85B |
| Total Liabilities | 5.26B | 4.27B | 4.29B | 4.11B | 3.56B |
| Shareholders' Equity | 1.63B | 1.52B | 1.07B | 1.08B | 1.28B |
| Total Debt | 1.89B | 1.41B | 1.49B | 1.32B | 1.03B |
| Cash & Equivalents | 84.80M | 97.30M | 89.50M | 104.70M | 124.60M |
| Current Assets | 3.78B | 3.26B | 3.09B | 3.05B | 2.81B |
| Current Liabilities | 3.63B | 2.89B | 2.90B | 2.72B | 2.43B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#540 of 1014
#153 of 654
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026